Abstract:Thymidylate synthase (TS), a key cancer chemotherapeutic target, catalyzes the conversion of deoxyuridylate to thymidylate. TS can serve as a repressor of its own synthesis by binding to its own mRNA through TS-specific binding elements (TBEs). In this report, we describe the use of a luciferase reporter plasmid containing two TBEs that can be used as a tool for the identification and initial profiling of compounds that modulate TS activity, levels, or ability to bind mRNA. To validate this model, we evaluated several groups of drugs. Thus, cells were exposed to the pyrimidine analogs 5-fluorouracil (5-FU), 5-fluorouridine (FUrd), 5-fluoro-2'-deoxyuridine (FUdR), trifluorothymidine (TFT); to the nonpyrimidine TS-inhibitors AG-331, nolatrexed (AG337), and raltitrexed (ZD1694); or to drugs with other primary sites of action (methotrexate, actinomycin D, 5-azacytidine, 8-thioguanosine). Except for 5-azacytidine and 8-thioguanosine, all compounds examined induced luciferase activity compared with untreated cells. Effects of luciferase activity inducing drugs through TS-affected translation were confirmed by examinations of TS protein and mRNA levels. Treatment of H630-C6 cells with 5-FU, FUrd, FUdR, TFT, AG331, AG337, ZD1694, and methotrexate up-regulated TS levels as determined by Western blot analysis, although TS mRNA levels remained unchanged as determined by reverse transcription-polymerase chain reaction. Our studies demonstrate a novel application of a TBE-dependent reporter plasmid that could be used for the high-throughput identification of potential chemotherapeutic agents that modulate TS RNA-binding activity, either directly or indirectly.

Translational autoregulation of thymidylate synthase and dihydrofolate reductase.

Thymidylate synthase as a translational regulator of cellular gene expression.

Translational Regulation As a Novel Mechanism for the Development of Cellular Drug Resistance

Characterization of a Cis-Acting Regulatory Element in the Protein Coding Region of Thymidylate Synthase Mrna

The Regulation of Protein Translation and Its Implications for Cancer

Altered Regulation of Message Stability and Tumor Promoter-Responsive Cis-Trans Interactions of Ribonucleotide Reductase R1 and R2 Messenger RNAs in Hydroxyurea-Resistant Cells.

Dynamic inter-domain transformations mediate the allosteric regulation of human 5, 10-methylenetetrahydrofolate reductase

rTS gene expression is associated with altered cell sensitivity to thymidylate synthase inhibitors

Translational Regulator Eif2α in Tumor

Identification of a cis-acting element of human dihydrofolate reductase mRNA

tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease

Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies

Novel Insight into the Regulatory Roles of Diverse RNA Modifications: Re-defining the Bridge Between Transcription and Translation

A System of RNA Modifications and Biased Codon Use Controls Cellular Stress Response at the Level of Translation

Role of Cysteine Amino Acid Residues on the RNA Binding Activity of Human Thymidylate Synthase

In Vitro Selection of an RNA Sequence That Interacts with High Affinity with Thymidylate Synthase.

Restricted tRNA methylation by intermolecular disulfide bonds in DNMT2/TRDMT1

Detection of Thymidylate Synthase Modulators by a Novel Screening Assay.

A Transfer-Rna-derived Small RNA Regulates Ribosome Biogenesis.

Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancer

tRNA and tsRNA: From Heterogeneity to Multifaceted Regulators